UNSPSC 51111831: Acolbifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C29H31NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 815LJ9X0D1, chemically known as 2h-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-, (2s) but generally known as acolbifene, which bears US NIH Compound Identifier 155435. Acolbifene most often comes in base and hydrochloride forms. Acolbifene also comes in hydrochloride form.

UNSPSC 51111831 Acolbifene, a Commodity code, addresses procurement of this selective estrogen receptor modulator (SERM) pharmaceutical compound by state and local health agencies, corrections departments, and institutional healthcare providers. Acolbifene is a prescription medication used primarily in hormone replacement therapy and related therapeutic applications; state and local governments procure it through pharmacy benefit managers, institutional formularies, and direct purchase agreements with pharmaceutical suppliers for distribution through public health systems, correctional medical services, and state hospital networks.

The most-recent-state-local-contract-opportunities block provided no active solicitations under this code. Without recent RFP, RFQ, IFB, or ITB activity in the source record, no geographic concentration, issuing-body mix, or representative opportunity detail can be reported.